Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University
About this trial
The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.
Eligibility criteria
Qualifiers
Male or female adults over the age of 18 years
Disqualifiers
History of a diagnosis of any gastrointestinal condition, such as inflammatory bowel syndrome or disease
Antibiotic usage within the past two weeks
Antifungal usage within the past month
Allergy to L-Phenylalanine or individuals with phenylketonuria (PKU)
Trial design
Treatments tested in this trial
- L-Phenylalanine 500 mg Veg Capsule product
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
1Belfer Research Building10022, New YorkNew York, United States
Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Source ClinicalTrials.gov